高药物负担指数多重用药改变肠道菌群并压过衰老效应,撤药后可逆转
该研究在纵向衰老小鼠中观察衰老、高药物负担指数(DBI)慢性多重用药及逐渐撤药对肠道菌群的影响。结果显示高DBI多重用药削弱了衰老相关的α多样性下降,撤药后该效应未持续;菌群多样性与衰弱、筑巢及旷场表现相关,但撤药12个月后菌群未恢复至治疗前组成。
要点
- 高DBI多重用药削弱衰老相关α多样性下降,撤药后未持续。
- 菌群多样性与衰弱、筑巢和旷场表现相关。
- 撤药可逆转治疗所致变化,但12个月未恢复至治疗前组成。
核心结论
- 衰老、慢性多重用药和撤药对肠道菌群多样性与组成的影响不同,且菌群变化与衰弱和功能相关。
研究设计与样本
- 纵向衰老小鼠研究,比较衰老、高DBI慢性多重用药及逐渐撤药对肠道菌群的影响,并探索与整体结局的关联。
主要发现
- 高DBI慢性多重用药削弱了衰老相关的α多样性下降,撤药后该效应未持续。
- β多样性和LEfSe特征随年龄、多重用药和撤药而变化。
- 伴或不伴多重用药的衰老均共享双歧杆菌科、副普雷沃菌科、拟杆菌科和梭菌科的减少,仅伴多重用药的衰老显示LEfSe特征增加。
- 菌群多样性与衰弱、筑巢和旷场表现相关。
- 撤药逆转了治疗期间发生的变化,但12个月时菌群未恢复至治疗前组成,也未出现对照组12至24个月时的衰老相关变化。
临床怎么用
- 在老年患者中评估高DBI多重用药对肠道菌群及衰弱、功能的潜在影响,撤药可能逆转部分菌群变化但恢复有限。
局限性
- 研究为小鼠纵向实验,结果向人类老年人群外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aging, medication use, and global function are associated with changes in the microbiome. However, their interrelationships and changes over time require further characterization. In a longitudinal aging mouse study, we investigated the effects of aging, chronic polypharmacy with a high Drug Burden Index (DBI, measure of total anticholinergic and sedative medication exposure) and gradual cessation (deprescribing) on the microbiome, further exploring any association with global outcomes. Chronic administration of high DBI polypharmacy attenuated the aging-related reduction in alpha diversity, which was not sustained after deprescribing. Beta diversity and LEfSe (Linear discriminant analysis Effect Size) features varied with age, polypharmacy, and deprescribing. Aging with and without polypharmacy shared decreases in Bifidobacteriaceae, Paraprevotellaceae, Bacteroidaceae, and Clostridiaceae, while only aging with polypharmacy showed increased LEfSe features. Microbiome diversity correlated with frailty, nesting, and open field performance. Polypharmacy deprescribing reversed changes that occurred with treatment. However, the microbiome did not recover to its pretreatment composition at 12 months, nor develop the same aging-related changes from 12 to 24 months as the control group. Overall, aging, chronic polypharmacy, and deprescribing differentially affected the diversity and composition of the gut microbiome, which is associated with frailty and function.
引用
- Gemikonakli G, Mach J, Zhang F, et al. Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing. J Gerontol A Biol Sci Med Sci. 2023. PMID: 36124741. doi:10.1093/gerona/glac195
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。